Overview

Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion

Status:
Completed
Trial end date:
2018-11-09
Target enrollment:
Participant gender:
Summary
Randomised controlled trial to contribute to the evidence base for the optimal initial insulin profile for adults with type 1 diabetes commencing insulin pump therapy.
Phase:
N/A
Details
Lead Sponsor:
Imperial College London
Treatments:
Insulin
Insulin, Globin Zinc